Showing results (241-250 of 261) with videos related to

Sort By:
Pageof 27
European Heart Journal|May 1, 2014
Effects of the high-density lipoprotein mimetic agent CER-001 on coronary atherosclerosis in patients with acute coronary syndromes: a randomized trialJean-Claude Tardif, Christie M Ballantyne, Philip Barter, et al.
Kidney International|February 21, 2024
Reassuring pregnancy outcomes in women with mild COL4A3-5-related disease (Alport syndrome) and genetic type of disease can aid personalized counselingMargriet E Gosselink, Rozemarijn Snoek, Agne Cerkauskaite-Kerpauskiene, et al.
European Journal of Preventive Cardiology|October 15, 2025
Future myocardial infarction after an acute coronary syndrome and pharmacogenetic response to dalcetrapibJean-Claude Tardif, Marc A Pfeffer, Simon Kouz, et al.
The New England Journal of Medicine|November 7, 2007
Effects of torcetrapib in patients at high risk for coronary eventsPhilip J Barter, Mark Caulfield, Mats Eriksson, et al.
Journal of Clinical Medicine|July 2, 2021
Global Variations in the Mineral Content of Bottled Still and Sparkling Water and a Description of the Possible Impact on Nephrological and Urological DiseasesSimone J M Stoots, Guido M Kamphuis, Rob Geraghty, et al.
European Heart Journal|July 20, 2022
Pharmacogenetics-guided dalcetrapib therapy after an acute coronary syndrome: the dal-GenE trialJean Claude Tardif, Marc A Pfeffer, Simon Kouz, et al.
Diabetes Care|January 5, 2024
Low-Dose Colchicine in Patients With Type 2 Diabetes and Recent Myocardial Infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)François Roubille, Nadia Bouabdallaoui, Simon Kouz, et al.
JAMA|June 23, 2011
Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysisDavid Preiss, Sreenivasa Rao Kondapally Seshasai, Paul Welsh, et al.
European Heart Journal|August 30, 2020
Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)Nadia Bouabdallaoui, Jean-Claude Tardif, David D Waters, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|May 15, 2020
Cost-effectiveness of low-dose colchicine after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)Michelle Samuel, Jean-Claude Tardif, Paul Khairy, et al.
Pageof 27